
Findings presented at the European Respiratory Society Congress 2026 suggest semaglutide may offer respiratory benefits beyond its approved diabetes and obesity indications.
Camber has announced the launch of Rosuvastatin, the generic version of Crestor tables from AstraZeneca, in 5-, 10-, 20-, and 40-mg tablets.
Camber has announced the launch of Rosuvastatin, the generic version of Crestor tables from AstraZeneca, in 5-, 10-, 20-, and 40-mg tablets. The drug is indicated to treat high cholesterol and triglyceride levels.
Rosuvastatin will be available in 90-count bottles of 5-, 10-, and 20-mg dosage strengths, as well as 30-count bottles of a 40-mg dosage strength.






